eli lilly - Search News

News

These Eli Lilly executives have been scooping up stock

These Eli Lilly executives have been scooping up stock after its big drop

Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in the aftermath of the selloff.

Benzinga · 44m

EVP Of Eli Lilly Purchased $634K In Stock

What Happened: Skovronsky demonstrated confidence in Eli Lilly by purchasing 1,000 shares, as reported in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The total value of the transaction is $634,405.

The Motley Fool · 2h

1 Reason to Buy Eli Lilly (LLY) Stock

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.

Texas Sues Eli Lilly Over Bribery Allegations

AOL · 1h

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant of bribing medical providers to promote its most profitable drugs, including the widely used GLP-1 medications Mounjaro and Zepbound for diabetes and weight loss.

PharmExec · 1h

Texas Sues Eli Lilly for Allegedly Bribing Providers to Prescribe Drugs

Attorney General Paxton argues that the company’s programs and offerings were essentially bribes and resulted in millions in dollars charged to the state’s Medicaid program.

Hoodline · 1h

Texas Attorney General Ken Paxton Targets Eli Lilly with Lawsuit Over Alleged Bribery Scandal in Big Pharma

Texas AG Ken Paxton sues Eli Lilly for alleged bribery to promote diabetes drugs, claiming violation of state fraud laws and exploitation of Medicaid.

4don MSN

Eli Lilly closer to breakthrough weight loss drug; shares tumble as some question results

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the ...

5hon MSN

Eli Lilly insider buying from CEO and others jump amid selloff

CEO David Ricks and other top executives have bought nearly $2.9B worth of company stock over the past few days as the ...

CNBCTV1833m

Eli Lilly launches Mounjaro KwikPen in India, priced from ₹14,000

The Mounjaro KwikPen, a multi-dose, prefilled device for single-patient use, is designed for convenient self-administration.

5don MSN

Eli Lilly Shares Plummet 14% Toward Worst Day In 25 Years—Here’s Why It’s Down

Eli Lilly on Thursday released data for its daily obesity pill, orforglipron, which found the medication helped obese or ...

21h

Eli Lilly: The Bears Have Spoken Loud And Clear (Upgrade)

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Click here to read an analysis of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results